Jose Vicente
Jose Vicente
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Verifierad e-postadress på fda.hhs.gov
Titel
Citeras av
Citeras av
År
Differentiating Drug‐Induced Multichannel Block on the Electrocardiogram: Randomized Study of Dofetilide, Quinidine, Ranolazine, and Verapamil
L Johannesen, J Vicente, JW Mason, C Sanabria, K Waite‐Labott, ...
Clinical Pharmacology & Therapeutics 96 (5), 549-558, 2014
1602014
An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel
WJ Crumb Jr, J Vicente, L Johannesen, DG Strauss
Journal of pharmacological and toxicological methods 81, 251-262, 2016
1262016
Drowsiness detection using heart rate variability
J Vicente, P Laguna, A Bartra, R Bailón
Medical & biological engineering & computing 54 (6), 927-937, 2016
1252016
Comprehensive translational assessment of human-induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias
K Blinova, J Stohlman, J Vicente, D Chan, L Johannesen, ...
Toxicological Sciences 155 (1), 234-247, 2016
1042016
Comprehensive T wave Morphology Assessment in a Randomized Clinical Study of Dofetilide, Quinidine, Ranolazine, and Verapamil
J Vicente, L Johannesen, JW Mason, WJ Crumb, E Pueyo, N Stockbridge, ...
Journal of the American Heart Association 4 (4), e001615, 2015
952015
Late sodium current block for drug‐induced long QT syndrome: Results from a prospective clinical trial
L Johannesen, J Vicente, JW Mason, C Erato, C Sanabria, K Waite‐Labott, ...
Clinical Pharmacology & Therapeutics 99 (2), 214-223, 2016
872016
Improving the Assessment of Heart Toxicity for All New Drugs through Translational Regulatory Science
L Johannesen, J Vicente, RA Gray, L Galeotti, Z Loring, CE Garnett, ...
Clinical Pharmacology & Therapeutics 95 (5), 501-508, 2014
662014
Detection of driver's drowsiness by means of HRV analysis
J Vicente, P Laguna, A Bartra, R Bailón
2011 Computing in Cardiology, 89-92, 2011
572011
Mechanistic Model‐Informed Proarrhythmic Risk Assessment of Drugs: Review of the “CiPA” Initiative and Design of a Prospective Clinical Validation Study
J Vicente, R Zusterzeel, L Johannesen, J Mason, P Sager, V Patel, ...
Clinical Pharmacology & Therapeutics 103 (1), 54-66, 2018
532018
Common Genetic Variant Risk Score is Associated with Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study
DG Strauss, J Vicente, L Johannesen, K Blinova, JW Mason, P Weeke, ...
Circulation, 2017
522017
Mechanisms of sex and age differences in ventricular repolarization in humans
J Vicente, L Johannesen, L Galeotti, DG Strauss
American heart journal 168 (5), 749-756. e3, 2014
472014
Electrocardiographic Biomarkers for Detection of Drug-Induced Late Sodium Current Block
J Vicente, L Johannesen, M Hosseini, JW Mason, PT Sager, E Pueyo, ...
PLOS ONE 11 (12), e0163619, 2016
322016
Automated Algorithm for J-Tpeak and Tpeak-Tend Assessment of Drug-Induced Proarrhythmia Risk
L Johannesen, J Vicente, M Hosseini, DG Strauss
PLOS ONE 11 (12), e0166925, 2016
272016
Comprehensive in vitro proarrhythmia assay (cipa) update from a cardiac safety research consortium/health and environmental sciences institute/fda meeting
DG Strauss, G Gintant, Z Li, W Wu, K Blinova, J Vicente, JR Turner, ...
Therapeutic innovation & regulatory science 53 (4), 519-525, 2019
262019
Evolving regulatory paradigm for proarrhythmic risk assessment for new drugs
J Vicente, N Stockbridge, DG Strauss
Journal of Electrocardiology 49 (6), 837-842, 2016
252016
TDR pressure cell for monitoring water content retention and bulk electrical conductivity curves in undisturbed soil samples
D Moret‐Fernández, J Vicente, B Latorre, F Lera, C Castañeda, MV López, ...
Hydrological Processes 26 (2), 246-254, 2012
232012
Assessing ECG signal quality indices to discriminate ECGs with artefacts from pathologically different arrhythmic ECGs
C Daluwatte, L Johannesen, L Galeotti, J Vicente, DG Strauss, CG Scully
Physiological Measurement 37 (8), 1370, 2016
202016
Assessment of Multi‐Ion Channel Block in a Phase I Randomized Study Design: Results of the Ci PA Phase I ECG Biomarker Validation Study
J Vicente, R Zusterzeel, L Johannesen, R Ochoa‐Jimenez, JW Mason, ...
Clinical Pharmacology & Therapeutics 105 (4), 943-953, 2019
182019
ECGlab: User friendly ECG/VCG analysis tool for research environments
J Vicente, L Johannesen, L Galeotti, DG Strauss
Computing in Cardiology 2013, 775-778, 2013
182013
Ecglib: Library for processing electrocardiograms
L Johannesen, J Vicente, L Galeotti, DG Strauss
Computing in Cardiology Conference (CinC), 2013, 951-954, 2013
162013
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20